Thursday, October 15, 2026

Coffee Futures Falls By 2% In The Last 5 Sessions

ViaNews Editorial Team

February 16, 2024

Coffee Futures Falls By 2% In The Last 5 Sessions

(VIANEWS) - Coffee (KC) has been up by 2.43% for the last 5 sessions. At 04:51 EST on Friday, 16 February, Coffee (KC) is $186.50.

Volume

Today's last reported volume for Coffee is 945, 95.38% below its average volume of 20485.44.

Volatility

Coffee's last week, last month's, and last quarter's current intraday variation average was 0.14%, 0.23%, and 2.95%, respectively.

Coffee's highest amplitude of average volatility was 2.18% (last week), 1.89% (last month), and 2.95% (last quarter), respectively.

News about

  • Crude oil tests multi-week high before receding on supply buildup, WTI back below $77.00. According to FXStreet on Wednesday, 14 February, "Despite testing into its highest bids in nearly three weeks, WTI saw a sharp pullback on Wednesday, setting US Crude Oil up for its first down day after seven consecutive closes in the green. ", "WTI slipped back below $77.00 per barrel after Energy Information Administration (EIA) barrel counts showed millions of barrels of excess Crude Oil supply piping through US markets that investors hadn't anticipated, chewing away at an overarching energy market narrative about global supply constraints that continue to fail to materialize."
  • WTI plunges to near $75.0 following a larger increase in US crude oil stockpiles. According to FXStreet on Thursday, 15 February, "West Texas Intermediate (WTI) Crude oil price declined following a larger-than-anticipated increase in US Crude Oil Stockpiles, which raised concerns about the demand outlook in the United States (US), the world's largest consumer of Crude oil products. ", "US Energy Information Administration showed that Crude Oil Stocks Change rose by 12.018 million barrels to 439.5 million barrels for the week ending on February 9. "

More news about Coffee (KC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com